TABLE 2.
Patients' admission diagnosis, underlying infectious diseases, etiological agents of infection, and CSF chemical statusa
Patient no. | Underlying CNS disease | Time from event (days) | Etiological agent(s) | Antibiotic cotreatment | HAD(s) | Protein concn in CSF (mg/liter) | WBC count in CSF (no. of cells/μl) | Glucose concn in CSF (mg/dl) |
---|---|---|---|---|---|---|---|---|
1 | Extradural hematoma | 12 | P. aeruginosa, MS S. aureus | Dopamine, mannitol | 150 | 1 | 93 | |
2 | Subarachnoid hemorrhage | 11 | Enterobacter spp. MS S. aureus | Dopamine, mannitol | 270 | 1 | 63 | |
3 | Subarachnoid hemorrhage | 9 | H. influenzae | Vancomycin | Dopamine, mannitol | 220 | 3 | 110 |
4 | Intracerebral hemorrhage | 10 | Klebsiella oxytoca | Dopamine, mannitol | 201 | 3 | 77 | |
5 | Intracerebral hemorrhage | 11 | E. coli | Dopamine, mannitol | 141 | 86 | 93 | |
6 | Subarachnoid hemorrhage | 9 | Proteus mirabilis | Dopamine, mannitol | 383 | 0 | 103 | |
7 | Intracerebral hemorrhage | 10 | Furosemide, mannitol | 413 | 3 | 114 | ||
8 | Subdural hemorrhage | 9 | MS S. aureus | Oxacillin | Mannitol | 220 | 1 | 181 |
9 | Frontal meningioma | 8 | P. aeruginosa | Piperacillin- tazobactam | Furosemide | 63 | 109 | 75 |
10 | Thalamic hemorrhage | 10 | MS S. aureus | Teicoplanin | Mannitol | 188 | 218 | 79 |
Total | 9.9 ± 1.2b | 224.9 ± 107.1b | 3 (0-218)c | 98.80 ± 33.19b |
All patients had ventilator-associated pneumonia. Abbreviations: HAD(s), hemodynamically active drug(s); MS, methicillin sensitive.
Data are expressed as means ± SDs.
Data are expressed as medians (ranges).